Consolidated Statements of Shareholders' Equity and Comprehensive Income (Loss) (USD $) | | | | | | | | | |
In Millions, except Share data | Preferred stock
| Series A common stock
Common stock
| Treasury stock
| Additional paid-in capital
| Retained earnings
| | Accumulated other comprehensive income (loss), net
| Noncontrolling interests
| Total
|
Balance as of the beginning of the period at Dec. 31, 2006 | $0 | $0 | $0 | $362 | $394 | | $31 | $74 | |
Balance as of the beginning of the period, shares outstanding at Dec. 31, 2006 | 9,600,000 | 158,668,666 | 0 | | | | | | |
Issuance of stock, shares outstanding | 0 | 7,400 | | | | | | | |
Issuance of stock | 0 | 0 | | | | | | | |
Indemnification of demerger liability | | | | 4 | | | | | |
Stock-based compensation, net of tax | | | | 15 | | | | | |
Stock option exercises, shares outstanding | | 4,265,221 | | | | | | | |
Stock option exercises, net of tax | | 0 | | 88 | | | | | |
Purchases of treasury stock, shares outstanding | | (10,838,486) | 10,838,486 | | | | | | |
Purchases of treasury stock, including related fees | | 0 | (403) | | | | | | |
Stock awards, shares outstanding | | 0 | | | | | | | |
Stock awards | | 0 | | | | | | | |
Net earnings (loss) attributable to Celanese Corporation | | | | | 426 | | | | 426 |
Series A common stock dividends | | | | | (25) | | | | |
Preferred stock dividends | | | | | (10) | | | | |
Adoption of ASC 740 | | | | | 14 | [1] | | | |
Purchase of remaining noncontrolling interests | | | | | | | | (70) | |
Divestiture of noncontrolling interests | | | | | | | | 0 | |
Net earnings (loss) attributable to noncontrolling interests | | | | | | | | 1 | 1 |
Comprehensive income (loss) | | | | | | | | | |
Net earnings (loss) | | | | | | | | | 427 |
Other comprehensive income (loss), net of tax | | | | | | | | | |
Unrealized gain (loss) on securities | | | | | | | 17 | | |
Foreign currency translation | | | | | | | 70 | | |
Unrealized gain (loss) on interest rate swaps | | | | | | | (41) | | |
Pension and postretirement benefits | | | | | | | 120 | | |
Balance as of the end of the period, shares outstanding at Dec. 31, 2007 | 9,600,000 | 152,102,801 | 10,838,486 | | | | | | |
Balance as of the end of the period at Dec. 31, 2007 | 0 | 0 | (403) | 469 | 799 | | 197 | 5 | 1,067 |
Issuance of stock, shares outstanding | 0 | 0 | | | | | | | |
Issuance of stock | 0 | 0 | | | | | | | |
Indemnification of demerger liability | | | | 2 | | | | | |
Stock-based compensation, net of tax | | | | 15 | | | | | |
Stock option exercises, shares outstanding | | 1,056,368 | | | | | | | |
Stock option exercises, net of tax | | 0 | | 9 | | | | | |
Purchases of treasury stock, shares outstanding | | (9,763,200) | 9,763,200 | | | | | | |
Purchases of treasury stock, including related fees | | 0 | (378) | | | | | | |
Stock awards, shares outstanding | | 109,739 | | | | | | | |
Stock awards | | 0 | | | | | | | |
Net earnings (loss) attributable to Celanese Corporation | | | | | 282 | | | | 282 |
Series A common stock dividends | | | | | (24) | | | | |
Preferred stock dividends | | | | | (10) | | | | |
Adoption of ASC 740 | | | | | 0 | [1] | | | |
Purchase of remaining noncontrolling interests | | | | | | | | 0 | |
Divestiture of noncontrolling interests | | | | | | | | (2) | |
Net earnings (loss) attributable to noncontrolling interests | | | | | | | | (1) | (1) |
Comprehensive income (loss) | | | | | | | | | |
Net earnings (loss) | | | | | | | | | 281 |
Other comprehensive income (loss), net of tax | | | | | | | | | |
Unrealized gain (loss) on securities | | | | | | | (23) | | |
Foreign currency translation | | | | | | | (130) | | |
Unrealized gain (loss) on interest rate swaps | | | | | | | (79) | | |
Pension and postretirement benefits | | | | | | | (544) | | |
Total Celanese Corporation shareholders' equity | | | | | | | | | 182 |
Balance as of the end of the period, shares outstanding at Dec. 31, 2008 | 9,600,000 | 143,505,708 | 20,601,686 | | | | | | |
Balance as of the end of the period at Dec. 31, 2008 | 0 | 0 | (781) | 495 | 1,047 | | (579) | 2 | 184 |
Issuance of stock, shares outstanding | 0 | 0 | | | | | | | |
Issuance of stock | 0 | 0 | | | | | | | |
Indemnification of demerger liability | | | | 0 | | | | | |
Stock-based compensation, net of tax | | | | 13 | | | | | |
Stock option exercises, shares outstanding | | 806,580 | | | | | | | |
Stock option exercises, net of tax | | 0 | | 14 | | | | | |
Purchases of treasury stock, shares outstanding | | 0 | 0 | | | | | | |
Purchases of treasury stock, including related fees | | 0 | 0 | | | | | | |
Stock awards, shares outstanding | | 81,781 | | | | | | | |
Stock awards | | 0 | | | | | | | |
Net earnings (loss) attributable to Celanese Corporation | | | | | 488 | | | | 488 |
Series A common stock dividends | | | | | (23) | | | | |
Preferred stock dividends | | | | | (10) | | | | |
Adoption of ASC 740 | | | | | 0 | [1] | | | |
Purchase of remaining noncontrolling interests | | | | | | | | 0 | |
Divestiture of noncontrolling interests | | | | | | | | (2) | |
Net earnings (loss) attributable to noncontrolling interests | | | | | | | | 0 | 0 |
Comprehensive income (loss) | | | | | | | | | |
Net earnings (loss) | | | | | | | | | 488 |
Other comprehensive income (loss), net of tax | | | | | | | | | |
Unrealized gain (loss) on securities | | | | | | | (3) | | |
Foreign currency translation | | | | | | | 5 | | |
Unrealized gain (loss) on interest rate swaps | | | | | | | 15 | | |
Pension and postretirement benefits | | | | | | | (97) | | |
Total Celanese Corporation shareholders' equity | | | | | | | | | 584 |
Balance as of the end of the period, shares outstanding at Dec. 31, 2009 | 9,600,000 | 143,394,069 | 20,601,686 | | | | | | |
Balance as of the end of the period at Dec. 31, 2009 | $0 | $0 | ($781) | $522 | $1,502 | | ($659) | $0 | $584 |
[1]Adoption of ASC 740, Income Taxes related to uncertain tax positions (Note 19). |